AI-driven risk prediction for thoracoscopy in suspected pleural malignancy: a proof-of-concept study - Amsterdam 2025

Malignant pleural effusions: diagnostic innovations and translational advances

Chair(s): Sotirios Zarogiannis, Maria Parsonage

Session type: Oral presentation

AI-driven risk prediction for thoracoscopy in suspected pleural malignancy: a proof-of-concept study

Adhnan Omar

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Targeting ADAM10 in Mesothelioma: Development of a Mesothelin-specific Dual-targeting Therapeutic Protein

Marco Morbidelli

Replay

Poster

Abstract

Slides

Increased Toll-Like Receptor 9 expression associated with cellular proliferation and poor prognosis in pleural mesothelioma

Fatma El Zahraa Mohamed

Poster

Abstract

Slides

Ultrasonic Elastography-guided versus Traditional Thoracic Ultrasound-guided Pleural Biopsy for the Diagnosis of Pleural Effusion: A Multicentre Randomized Trial

Mingming Deng

Replay

Poster

Abstract

Slides

AESOP A randomised controlled crossover study of indwelling pleural catheter drainage systems in malignant pleural effusions

Rebecca Crook

Replay

Poster

Abstract

Slides

A binary survival model, incorporating Fibulin-3, predicts survival in pleural mesothelioma

Harrison Stubbs

Replay

Poster

Abstract

Slides

AI-driven risk prediction for thoracoscopy in suspected pleural malignancy: a proof-of-concept study

Adhnan Omar

Poster

Abstract

Slides

Results of the STRATIFY study (Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion)

Jenny Ferguson

Replay

Poster

Abstract

Slides

Know the Harm to Do No Harm: A Retrospective Review of Iatrogenic pneumothorax managed at a single centre over 8 years

Beenish Iqbal

Replay

Poster

Abstract

Slides

Genetic susceptibility in MAlignant pleural mesothelioma: clinical implication of GermliNE variaTionS (the MAGNETS project).

Ilaria Campo

Replay

Poster

Abstract

Slides

Adequacy of cell-free DNA from pleural effusion supernatant for oncogenic mutations detection

Tiva Nemanic

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}